Enveda Biosciences Appoints José Trevejo M.D. Ph.D. as Chief Medical Officer and Head of Clinical Pipeline Strategy
Position
Head of Clinical Pipeline Strategy
Company
Enveda Therapeutics, Inc.
BoulderOtherBiotechnologyDescription
Enveda Biosciences has appointed José Trevejo M.D. Ph.D. as the Chief Medical Officer and Head of Clinical Pipeline Strategy
Quick answer
Enveda Biosciences Appoints José Trevejo M.D. Ph.D. as Chief Medical Officer and Head of Clinical Pipeline Strategy (August 1, 2024). Enveda Therapeutics, Inc. is based in Boulder, Colorado, United States.
- Who is the new Head of Clinical Pipeline Strategy at Enveda Therapeutics, Inc?
- Enveda Therapeutics, Inc. named José Trevejo M.D. Ph.D. Head of Clinical Pipeline Strategy, announced August 1, 2024.
- What did Enveda Therapeutics, Inc. announce on August 1, 2024?
- Enveda Biosciences has appointed José Trevejo M.D. Ph.D. as the Chief Medical Officer and Head of Clinical Pipeline Strategy
- What does Enveda Therapeutics, Inc. do?
- Enveda Biosciences is a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery.
- Where is Enveda Therapeutics, Inc. based?
- Enveda Therapeutics, Inc. is based in Boulder, Colorado, United States.
- Which similar companies made leadership changes around the same time?
- Jade Biosciences (August 1, 2024), Constellation Research (August 1, 2024), Equinox (August 1, 2024) and Accelerated Cure Project (July 31, 2024) also announced leadership changes within 45 days of Enveda Therapeutics, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jade Biosciences Names Andrew King as Chief Scientific Officer (August 1, 2024)
- Constellation Research Appoints Barbara Costello as Vice President, Market and Research Development to Drive Revenue Growth (August 1, 2024)
- Equinox Appoints Marc Mastronardi as President (August 1, 2024)
- Accelerated Cure Project (ACP) Appoints Stephanie Buxhoeveden as Chief Scientific Officer (CSO) (July 31, 2024)
- myTomorrows Appoints Iskra Reic as Independent Director (July 31, 2024)
- AES Appoints Dr. Mark Lies as Chief Technology Officer and Dr. Matthew Courtney as Chief Sales Officer (August 2, 2024)
Who to call at Enveda Therapeutics, Inc., and when
A new leader at Enveda Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Enveda Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enveda Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enveda Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enveda Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enveda Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.